|
Apr 25
|
Stocks to watch next week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca
|
|
Apr 23
|
Update: Novartis, Sanofi CEOs Say EU Should Hike Drug Prices to Boost Innovation
|
|
Apr 23
|
Novartis, Sanofi CEOs Say EU Should Hike Drug Prices to Boost Innovation
|
|
Apr 23
|
Why Novartis (NVS) is a Top Momentum Stock for the Long-Term
|
|
Apr 23
|
Incyte Gears Up to Report Q1 Earnings: Here's What You Should Know
|
|
Apr 23
|
European pharma companies push for higher drug prices in EU amid U.S. tariff threats
|
|
Apr 21
|
Novartis to Report Q1 Earnings: Will Key Drugs Maintain Momentum?
|
|
Apr 18
|
Why Novartis (NVS) is a Top Dividend Stock for Your Portfolio
|
|
Apr 15
|
Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke
|
|
Apr 14
|
Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains?
|
|
Apr 14
|
The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis
|
|
Apr 11
|
Novartis Commits $23 Billion to U.S. Expansion, Eyes Full Domestic Production of Key Medicines
|
|
Apr 11
|
NVS Plans to Invest $23B in US Manufacturing Sites Amid Tariff Threat
|
|
Apr 11
|
Novartis commits $23bn to US manufacturing amid tariff threats
|
|
Apr 11
|
Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More
|
|
Apr 11
|
Novartis Stock Rises After Swiss Drugmaker Promises to Boost U.S. Manufacturing
|
|
Apr 11
|
Sector Update: Health Care Stocks Mixed Premarket Friday
|
|
Apr 11
|
This Pharma Giant Will Invest $23 Billion in the U.S. It’s a Sign Trump’s Tariffs Are Working.
|
|
Apr 10
|
Novartis Plans $23B Investment in US Facilities as Trump Threatens Pharma Tariffs
|
|
Apr 10
|
Swiss Drugmaker Novartis Promises to Boost U.S. Manufacturing Amid Tariff Threats
|